Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Epstein-Barr Virus Specific Cytotoxic T Cells for Clinical Use in Immune Reconstitution Post Haemopoietic Stem Cell Transplant.

Emily Blyth, B., Med, (Hons), FRACP, FRCPA, Leighton E Clancy, Upinder Sandher, Rajiv Khanna, BSc, MSc, PhD, David J Gottlieb

Blood (2009) 114 (22): 2435.

https://doi.org/10.1182/blood.V114.22.2435.2435

Published: 2009

Journal Articles

BK Virus Specific Cytotoxic T Cells Expanded for Clinical Use Exhibit Multiple Cytokine Functions and Individual Variation in Antigen Specificity.

Emily Blyth, Leighton E Clancy, Upinder Sandher, David J Gottlieb

Blood (2009) 114 (22): 2437.

https://doi.org/10.1182/blood.V114.22.2437.2437

Published: 2009

Journal Articles

CMV Specific T Cells for Adoptive Transfer Exhibit Multiple Effector Functions Associated with Protective Immunity Including the Concurrent Production of Cytokines and Cytolytic Activity

Leighton E Clancy, Kenneth P Micklethwaite, Emily Blyth, Upinder Sandher, David J Gottlieb, MD, FRACP, FRCPA

Blood (2008) 112 (11): 3481.

https://doi.org/10.1182/blood.V112.11.3481.3481

Published: 2008

Journal Articles

Prophylactic infusion of cytomegalovirus-specific cytotoxic T lymphocytes stimulated with Ad5f35pp65 gene-modified dendritic cells after allogeneic hemopoietic stem cell transplantation

Kenneth P. Micklethwaite, Leighton Clancy, Upinder Sandher, Anna M. Hansen, Emily Blyth, Vicki Antonenas, Mary M. Sartor, Kenneth F. Bradstock, David J. Gottlieb

Blood (2008) 112 (10): 3974–3981.

https://doi.org/10.1182/blood-2008-06-161695

Published: 2008

Journal Articles

Donor Lymphocytes Stimulated with CMV pp65 Gene Modified Dendritic Cells for Prophylaxis of CMV Following Allogeneic Haemopoietic Stem Cell Transplantation.

Kenneth P. Micklethwaite, MBBS, Leighton E. Clancy, B.Sc, PhD, Upinder Sandher, B.Sc, Elizabeth Snape, BNURS, Kenneth Francis Bradstock, MD, PhD, David J. Gottlieb, MD

Blood (2007) 110 (11): 2989.

https://doi.org/10.1182/blood.V110.11.2989.2989

Published: 2007

NARROW

Epstein-Barr Virus Specific Cytotoxic T Cells for Clinical Use in Immune Reconstitution Post Haemopoietic Stem Cell Transplant.

BK Virus Specific Cytotoxic T Cells Expanded for Clinical Use Exhibit Multiple Cytokine Functions and Individual Variation in Antigen Specificity.

CMV Specific T Cells for Adoptive Transfer Exhibit Multiple Effector Functions Associated with Protective Immunity Including the Concurrent Production of Cytokines and Cytolytic Activity

Prophylactic infusion of cytomegalovirus-specific cytotoxic T lymphocytes stimulated with Ad5f35pp65 gene-modified dendritic cells after allogeneic hemopoietic stem cell transplantation

Donor Lymphocytes Stimulated with CMV pp65 Gene Modified Dendritic Cells for Prophylaxis of CMV Following Allogeneic Haemopoietic Stem Cell Transplantation.

Email alerts

ASH Publications

American Society of Hematology

Epstein-Barr Virus Specific Cytotoxic T Cells for Clinical Use in Immune Reconstitution Post Haemopoietic Stem Cell Transplant.

BK Virus Specific Cytotoxic T Cells Expanded for Clinical Use Exhibit Multiple Cytokine Functions and Individual Variation in Antigen Specificity.

CMV Specific T Cells for Adoptive Transfer Exhibit Multiple Effector Functions Associated with Protective Immunity Including the Concurrent Production of Cytokines and Cytolytic Activity

Prophylactic infusion of cytomegalovirus-specific cytotoxic T lymphocytes stimulated with Ad5f35pp65 gene-modified dendritic cells after allogeneic hemopoietic stem cell transplantation

Donor Lymphocytes Stimulated with CMV pp65 Gene Modified Dendritic Cells for Prophylaxis of CMV Following Allogeneic Haemopoietic Stem Cell Transplantation.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only